Aug 23, 05
|
| NEW STORY |
| 17:00 ET |
Lantos Affirms Support of Expanded Stem Cell Research - Applauds Commitment by VistaGen Employees and Investors
|
|
Aug 11, 05
|
| 07:15 ET |
VistaGen Therapeutics Secures Development Support for New Drug Candidate for Huntington's Disease
|
|
Jul 12, 05
|
| 07:15 ET |
VistaGen Therapeutics Awarded $197,000 NIH Grant for Expanded Preclinical Development of New Drug Candidate for Neuropathic Pain
|
|
May 24, 05
|
| 07:15 ET |
VistaGen Therapeutics Awarded $3,700,000 NIH Drug Development Grant for Lead Epilepsy Drug Candidate
|
|
Nov 04, 04
|
| 07:08 ET |
VistaGen Secures More Key Embryonic Stem Cell Technology for Leading Edge Diabetes Research
|
|
Oct 14, 04
|
| 07:15 ET |
VistaGen Creates Clinical Advisory Board
|
|
Oct 13, 04
|
| 07:15 ET |
VistaGen Therapeutics and Sanwa Announce First Embryonic Stem Cell Research Partnership Focused on New Treatments for Diabetes
|
|
Aug 31, 04
|
| 07:15 ET |
VistaGen Expands Board and Senior Management
|
|
Jan 12, 04
|
| 07:15 ET |
VistaGen Awarded NIH Research Grant for Advanced Preclinical Development of Lead Epilepsy Drug Candidate
|
|
Nov 19, 03
|
| 07:15 ET |
VistaGen Therapeutics Acquires Artemis Neuroscience, Inc. - Enters Late-Stage Preclinical Development Program for Lead Epilepsy Drug Candidate -
|
|
Apr 08, 03
|
| 07:15 ET |
VistaGen Therapeutics and Sanwa Announce Stem Cell Biology Partnership And Financing
|
|
Sep 04, 02
|
| 07:45 ET |
VistaGen Awarded $1.7 Million NIH Phase 2 SBIR Grant for Novel Stem Cell-Based Predictive Assays
|
|
Jul 09, 02
|
| 07:45 ET |
VistaGen Receives NIH Funding for Development of Biomathematical Models Of Molecular Toxicity
|
|
Apr 15, 02
|
| 07:15 ET |
VistaGen Therapeutics and Novartis Sign Murine Stem Cell Partnership To Explore New in Vitro Toxicity Models for Drug Candidates
|
|
|